Inhibitory effect of adrenocorticolytic drug mitotane on corticotropin and prolactin binding by isolated cells and microsomal membranes of human and guinea pig adrenocorticocytes

Experimental Oncology

Volumn 19, Issue 2, 1997, Pages 162-166

  Mikosha, A S ^a   Sautin, Yu Yu ^a   Kovzun, E I ^a   Povorotnij, V Yu ^a   Tronko, N D ^a  

^a STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

Author keywords

ACTH; adrenal tumor; mitotane; o,p' DDD; prolactin

Indexed keywords

CORTICOTROPIN; MITOTANE; PROLACTIN;

ADRENAL CORTEX CELL; ADRENAL TUMOR; ANIMAL CELL; ARTICLE; CELL MEMBRANE; GUINEA PIG; HUMAN; HUMAN CELL; ISOTOPE LABELING; MICROSOME; NONHUMAN;

EID: 0030874219     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Luton J-P, Cerdas S, Billaud L, Thomas G, Guilhaume B, Bertagna X, Laudat M-H, Louvel A, Chapuis Y, Blondeau P. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990; 322: 1195-201.
2. Wooten MD, King DK. Adrenal cortical carcinoma: Epidemiology and treatment with mitotane and a review of the literature. Cancer 1993; 72: 3145-55.
3. Haak HR, Hermans J, Vandevelde CJH, Lentjes EGWM, Gosllings BM, Fleuren GJ, Krans HMJ. Optimal treatment of adrenocortical carcinoma with mitotane: Results in a consecutive series of 96 patients. Brit J Cancer 1994; 69: 947-51.
4. Kornely E, Schlaghecke R. Complete remission of metastasized adrenocortical carcinoma under o,p′-DDD. Exp Clin Endocrinol 1994; 102: 50-3.
5. Slavnov VN, Luchitsky EV, Komissarenko IV, Cheban AK. Glucocorticoid function of the adrenals in patients with Icenko-Cushing's disease treated with chloditane. Klinicheskaya Meditsina 1979; (1): 60-4 (in Russian).
6. Komissarenko VP, Mikosha AS, Polovko EP. The action of o,p′-dichlordiphenyldichloroethane (o,p′-DDD) on the ATPases of the adrenal cortex. Problemy Endocrinologii 1978; (2): 85-9 (in Russian).
7. Mikosha AS. Swelling of adrenal mitochondria under the effect of o,p′-dichlorodiphenyldichloroethane. Dokl Acad Nauk Ukr SSR Ser B 1984; (7): 68-70 (in Russian).
8. Komissarenko VP, Mikosha AS, Chelnakova IS. Changes in the mitochondrial and microsomal electron transport under the influence of 1-(o-chlorophenyl)-1-chlorophenyl)-2,2-dichloroethane. Ukr Biochim Zhurn 1981; (6): 74-7 (in Russian).
9. Posner BI, Kelly PA, Shiu RPC, Friesen HG. Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization. Endocrinology 1974; 95: 521-31.
10. Tronko ND, Pushkarev VM, Bogdanova TI, Sautin YuYu, Mikosha AS. Isolation and fractionation in Percoll gradient of adrenocortical cells of guinea pig and the characterization of their functional state. Fiziologicheskii Zhurn 1989; 35 (4): 52-61 (in Russian).
11. Hunter WM, Greenwood FC. Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 1962; 194: 495-6.
12. Suard YML, Kraehenbuhl J-P, Aubert ML. Dispersed mammary epithelial cells. Receptors of lactogenic hormones in virgin, pregnant, and lactating rabbits. J Biol Chem 1979; 254: 10466-75.
13. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
14. Buff K, Brundl A, Berndt J. Interaction of insecticide 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane with the β-receptor adenylate cyclase system in Chang liver cell membranes. Chem-Biol Interact 1983; 47: 337-46.
15. Buff K, Brundl A. Selective alterations of membrane properties of cultured human liver cells caused by the insecticide DDT. Pestic Biochem Physiol 1984; 22: 36-42.
16. Ishikawa Y, Charalambous P, Matsumura F. Modification by pyrethroids and DDT of phosphorylation activities of rat brain sodium channel. Biochem Pharmacol 1989; 38: 2449-57.
17. Antunes-Madeira MC, Madeira VMC. Effects of DDE on the fluidity of model and native membranes: implications for the mechanisms of toxicity. Biochim Biophys Acta 1993; 1149: 86-92.
18. Videira RA, Antunes-Madeira MC, Custodio JBA, Madeira VMC. Partition of DDE in synthetic and native membranes determined by ultraviolet derivative spectroscopy. Biochim Biophys Acta 1995; 1238: 22-8.
19. Touitou Y, Moolenaar AJ, Bogdan A, Auzeby A, Luton J-P. o,p′-DDD (mitotane) treatment for Cushing's syndrome: adrenal drug concentration and inhibition in vitro of steroid synthesis. Eur J Clin Pharmacol 1985; 29: 483-7.
20. Benecke R, Keller E, Vetter B, Dezeeuw RA. Plasma level monitoring of mitotane (o,p′-DDD) and its metabolite (o,p′-DDE) during long-term treatment of Cushing's disease with low doses. Eur J Clin Pharmacol 1991; 41: 259-61.